Recent developments in optical detection technologies, biomaterials, molecular diagnostics, and microfluidics offer exciting new opportunities for biodefense and Point of Care (POC) applications, with significant improvements in sensitivity, multiplexing, and detection of molecules that were previously unattainable with traditional lateral flow devices. However, POC product development is a complex process involving the integration of a bioassay with consumable cartridges and detection instruments. Consumable component development is often one of the most critical elements. At the early stages of product development, it is imperative to design components for high volume manufacturability, along with flexibility in design revision in order to accommodate assay development and integration needs.
展开▼
